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Summary 
Growth hormone receptor (GHR) forms a complex with 
a tyrosine kinase, suggesting involvement of a ligand- 
activated tyrosine kinase in intracellular signaling by 
growth hormone (GH). Here we identify JAK2, a nonre- 
ceptor tyrosine kinase, as a GHR-associated tyrosine 
kinase. Immunological approaches were used to es- 
tablish OH-dependent complex formation between 
JAK2 and GHR, activation of JAW tyrosine kinase ac- 
tivity, and tyrosyl phosphorylation of both JAK2 and 
GHR. The JAK2-GHR and JAK2-erythropoietin recep- 
tor interactions described here and in the accompa- 
nying paper provide a molecular basis for involvement 
of tyrosyl phosphorylation in physiological responses 
to these ligands and suggest a shared signaling mech- 
anism among members of the cytokine/hematopoietin 
receptor family. 
Introduction 
Although the ability of growth hormone (GH) to promote 
growth and regulate metabolism has been known for many 
years (Cheek and Hill, 1974; Davidson, 1987) the molecu- 
lar mechanism by which GH binding to its receptor elicits 
its diverse responses has remained an enigma. New in- 
sight into GH signaling mechanisms was recently provided 
by the demonstration that a tyrosine kinase is present in 
a complex with GH receptor (GHR) prepared from GH- 
treated ceils (Carter-Su et al., 1989; Stred et al., 1992; 
Wang et al., 1992). Additional studies in 3T3-F442A cells 
showing rapid GHdependent tyrosyl phosphorylation of 
multiple proteins, tyrosyl phosphorylation of microtubule- 
associated protein kinases, and stimulation of microtu- 
bule-associated protein kinase activity, as well as the inhi- 
bition of these actions by inhibitors of the GHR-associated 
tyrosine kinase (Campbell et al., 1993) suggest a central 
role for a GHR-associated tyrosine kinase in signaling by 
GH. Recently, a nonreceptor tyrosyl phosphorylated 121 
kd protein was identified in a kinase-active GH-GHR prep- 
aration (Wang et al., 1993). Since autophosphorylation is 
often a manifestation of an activated kinase, it was hypoth- 
esized that this 121 kd phosphoprotein is the GHR- 
associated kinase. 
In this study, we identify JAKP, a 130 kd tyrosine kinase 
(Silvennoinen et al., 1993; Harpur et al., 1992) as aGHR- 
associated kinase. JAK2 is a member of the recently de- 
scribed Janus family of tyrosine kinases consisting of 
JAKl , JAK2, and Tyk2. In addition to having a kinase do- 
main, these proteins are characterized by the presence 
of a second kinase-like domain and the absence of Src 
homology 2 (SH2), SH3, and membrane-spanning do- 
mains (Wilks et al., 1991; Firmbach-Kraft et al., 1990; 
Harpur et al., 1992; Silvennoinen et al., 1993). Members 
of the JAK family were thought to be good candidates for 
the GHR-associated tyrosine kinase because of their size 
(M, of - 130,000), their presence in GH-responsive tis- 
sues, and the ability of Tyk2 to serve as a signaling mole- 
cule for the interferon al8 (IFN-a/8) receptor, a receptor 
distantly related to GHR (Harpur et al., 1992; Silvennoinen 
etal., 1993; Wilksetal., 1991;Firmbach-Kraftetal., 1990; 
Bazan, 1990; Velazquez et al., 1992). Here we show that 
GH binding promotes association of JAK2 with GHR, acti- 
vation of JAK2, and tyrosyl phosphorylation of both JAK2 
and GHR. The identification of JAK2 as a signaling mole- 
cule early in the GHR signal transduction pathway pro- 
vides important insight into signaling by GHR and into the 
function of JAK2. Work presented in the accompanying 
paper (Witthuhn et al., 1993 [this issue of Cc//j) indicates 
that JAK2 also associates with the receptor for erythropoi- 
etin (EPO), and other data indicate that at least four other 
members of the cytokinelhematopoietin receptor family 
(receptors for interleukin [IL]-3), granulocyte-macrophage 
colony-stimulating factor (GM-CSF], granulocyte colony- 
stimulating factor [G-CSF], and prolactin) and the more 
distantly related lFN--r receptor activate JAKP (Silven- 
noinen et al., 1993; Witthuhn et al., 1993; 0. S. et al., 
unpublished data; G. S. C. et al., unpublished data). It 
therefore seems likely that the JAK2-GHR and JAK2- 
EPO receptor interactions shown in this paper and by Wit- 
thuhn et al. (1993) will serve as prototypes for signaling 
through many members of this large receptor superfamily. 
Results 
GH Stimulates Tyrosyl Phosphorylation of JAK2 
On the basis of previous studies establishing the existence 
of a GHR-associated tyrosine kinase (Carter-Su et al., 
1989; Stred et al., 1992; Wang et al., 1993; Campbell et 
al., 1993), the GHR-associated tyrosine kinase would be 
expected: first, to be a protein of - 120 kd; second, to 
be tyrosyl phosphorylated in response to GH; third, to be 
present in a complex with GHR; and fourth, to exhibit in- 
creased activity in response to GH. 
JAK2 is a tyrosine kinase of the correct size (M, of 
- 130,000; Silvennoinen et al., 1993) to be the GHR- 
associated kinase and was therefore tested for its ability to 
be phosphorylated in response to GH. Solubilized proteins 
from GH-treated 3T3-F442A fibroblasts were immunopre- 
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cipitated using antiserum to JAKP (aJAK2) and analyzed 
by anti-phosphotyrosine antibody (aPY) immunoblot (Fig- 
ure 1A). GHdependent tyrosyl phosphorylation of a pro- 
tein with an M, (- 130,000) appropriate for JAK2 (Silven- 
noinen et al., 1993) was clearly evident at times as early 
as 30 sand at physiological concentrations of GH as low as 
5.0 nglml(230 PM). Phosphorylation was transient, being 
greatly diminished by 60 min after addition of GH. The 
appearance of the 130 kd phosphoprotein in aPY immu- 
noblots of aJAK2 immunoprecipitates (Figure lA, lanes 
A-E and K-O) corresponds in time course and GH dose 
response with the appearance in whole-cell lysates of a 
tyrosyl-phosphorylated protein, indicated by the arrow in 
Figure 1A (lanes F-J and P-T) and designated pp121 in 
previous work (Campbell et al., 1993; Wang et al., 1993). 
The identity of these two proteins is suggested by the comi- 
gration in cell lysates of tyrosyl phosphotylated ppl21 and 
JAKP (Figure 1 B) and the depletion of tyrosyl-phosphoty- 
lated pp121 from cell lysates following immunoprecipita- 
tion with aJAK2 (Figure 1C). 
The 130 kd phosphoprotein was precipitated specifically 
by aJAK2 (Figures 2A and 28, lanes B). Nonimmune 
serum (Figure 2A, lane A), an unrelated immune serum 
(aGLUT-1; Figure 2A, lane C), and aJAK2 preadsorbed 
with the peptide used to make the antibody (Figure 28, 
lane 0) failed to immunoprecipitate ~~130. Preadsorption 
of aJAK2 with the analogous peptide from murine JAKl 
(Silvennoinen et al., 1993) did not interfere with precipita- 
Figure 1. GH Promotes Tyrosyl Phosphoryla- 
tion of JAK2 
(A) 3T3-F442A fibroblasts were incubated with 
the indicated concentrations of hGH for the 
times shown. Whole-cell lysates were immuno- 
precipitated with aJAK2 (I:500 dilution). Immu- 
noprecipitated proteins (lanes A-E and K-C) 
and unfractionated lysates (lanes F-J and P-T) 
were subjected to Western blot analysis using 
aPY-4GlO. The decreased intensity of all the 
bands in lane H in comparison with the bands 
in the other lanes (including the 0 time point) 
suggests that lane H contains proteins from 
fewer cells than the other lanes. 
(B) Whole-cell lysates of 3T3-F442A fibroblasts 
incubated without (lanes A and C) or with (lanes 
B and D) 500 rig/ml hGH for 5 min were sub- 
jected to Western blot analysis with either 
aPY4GlO (lanes A and B) or aJAK2 (lanes C 
and D). 
(C) Cell lysates from 3T3-F442A fibroblasts 
stimulated with 500 rig/ml hGH for 5 min were 
immunoprecipitated with aJAK2 (1 :lOOO) and 
Western blotted with aPY-4G10. Lane A, total 
lysate; lane B, supernatant following immuno- 
precipitation with aJAK2; lane C, aJAK2 immu- 
noprecipitate. All lanes represent equivalent 
amounts of cell lysate. When assessed by den- 
sitometry, the amount of ppl21 removed by the 
aJAK2 treatment is found to be equal (within 
5%) to the amount of tyrosyl-phosphorylated 
protein appearing in the oJAK2 immunoprecip- 
itate. The migration of pp121 in whole-cell ly- 
sates is denoted by the arrow. The migration 
of pp130 is denoted. 
tion of the 130 kd phosphoprotein by aJAK2 (Figure 2B, 
lane F). In contrast with these results using aJAK2, immu- 
noprecipitation of 3T3-F442A and IM-9 cell lysates, re- 
spectively, with antibodies specific for JAKl (aJAK1) and 
Tyk2 (aTyk2) revealed little (aJAK1) or no (aTyk2) GH- 
dependent tyrosyl phosphorylation of a - 130 kd protein, 
despite the presence of these kinases in the respective 
cell types (data not shown). 
Tyrosyl phosphorylation of the 130 kd protein precipi- 
tated from 3T3-F442A cells by aJAK2 was increased spe- 
cifically by GH. Phosphorylation was not increased by 
plateletderived growth factor, epidermal growth factor, or 
insulin-like growth factor 1 (Figure 2A, lanes E-G, respec- 
tively). These growth factors stimulate tyrosine kinase ac- 
tivity intrinsic to their receptors (Ullrich and Schlessinger, 
1990) and promote tyrosyl phosphorylation of multiple pro- 
teins in 3T3-F442A fibroblasts (Campbell et al., 1993). The 
inability to stimulate JAKP tyrosyl phosphotylation is con- 
sistent with the previously reported inability of these 
growth factors to stimulate tyrosyl phosphorylation of 
pp121 in whole-cell lysates (Campbell et al., 1993). 
JAK2 Associates with the GH Receptor 
To determine whether JAK2 forms a complex with GHR, 
GH-GHR complexes and associated proteins were immu- 
noprecipitated from solubilized, GH-treated 3T3-F442A fi- 
broblasts using antibody to GH (aGH). The presence of 
JAK2 in aGH immunoprecipitates was assessed either by 
JA;2 Is a GHR-Associated Tyrosine Kinase 
A ABC D E F G B ABCDEF 
pp130 - pp130- use *I 
Stimulus: GH GH GH - P E I GH: - + - + - + 
NI: + _ _ _ _ _ _ Peptide: None JAK2 JAKl 
aJAK2: - + - + + + + 
aGlut1: - - + - - - - 
immunoblotting with aJAK2 or by immunoprecipitating 
with aJAK2 and immunoblotting with aPY. When material 
precipitated using aGH was analyzed, aJAK2 was found 
to immunoblot a 130 kd protein (Figure 3, lane B) and to 
immunoprecipitate a tyrosyl-phosphorylated 130 kd pro- 
tein (Figure 3, lane L) that comigrates with a protein recog 
nized by aJAK2 (Figure 3, lane M), indicating that JAK2 
associates with GH-GHR complexes. When instead of 
aGH, the initial immunoprecipitation was performed with 
antibody to either the cytoplasmic (Figure 3, lanes C and D) 
or extracellular (data not shown) domains of GHR (aGHR), 
aJAK2 recognized a 130 kd protein only when cells had 
been incubated with GH. Consistent with the presence of 
JAK2 in the aGHR precipitate because of its association 
with GH-bound GHR, no signal was detected in aJAK2 
immunoblots of aGH immunoprecipitates when cells had 
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Figure 2. Tyrosyl Phosphorylation of JAK2 Is 
Specific to GH Stimulation 
(A) Cell lysates from unstimulated 3T3-F442A 
fibroblasts (lane 0) and from cells stimulated 
for 5 min with 500 rig/ml hGH (lanes A-C), 25 
nglml platelet-derived growth factor (lane E), 
125 nglml epidermal growth factor (lane F), or 
200 nglml insulin-like growth factor 1 (lane G) 
were subjected to immunoprecipitation with 
aJAK2(1 :lOOO; lanes Band D-G), nonimmune 
serum (1:lOOO; lane A), or an irrelevant antise- 
rum (aGLUT-1, 1:lOOO; lane C) (Tai et al., 
1990) as described in Figure 1. The immuno- 
precipitates were analyzed by Western blot 
analysis with aPY4GlO. 
(8) Cell lysates from unstimulated 3T3-F442A 
fibroblasts (lanes A, C, and E) and from cells 
stimulated for 5 min with 500 nglml hGH (lanes 
8, D, and F) were subjected to immunoprecipi- 
tation with aJAK2 (1:loOO; lanes A and B), 
aJAK2 (1 :lOOO) that had been preincubated for 
1 hr at 0% with the peptide (30 Kg/ml) used 
as antigen to make eJAK2 (lanes C and D; Sil- 
vennoinen et al., 1993) or a peptide analogous 
to amino acids 795-504 of JAKl (lanes E and 
F; Silvennoinen et al., 1993). 
not been incubated with GH (Figure 3, lane A) nor when 
immunoprecipitation was performed using an unrelated 
immune serum (aGLUT-1) (data not shown). These results 
provide evidence that GH binding to its receptor is neces- 
sary for the formation of a complex between GHR and 
JAKP. 
In addition to the 130 kd phosphoprotein believed to be 
JAK2, a diffusely migrating phosphoprotein of - 120 kd 
identified by aPY immunoblot was precipitated by aGH 
(Figure 3, lanes F and J), aGHR (Figure 3, lane H), and 
to a lesser extent aJAK2 (Figure 3, lane K). Consistent 
with this diffuse band being GHR, its size corresponds to 
that previously reported for GHR in these cells (Schwartz 
and Carter-Su, 1988; Stred et al., 1992), and it comigrates 
with a similarly diffuse - 120 kd band identified by aGHR 
in Western blots of aGH immunoprecipitates (Figure 3, 
K LM Figure 3. GH Promotes Complex Formation 
between GHR and JAK2 and Promotes Tyrosyl 
Phosphorylation of GHR and JAK2 
3T3-F442A fibroblasts were incubated with ve- 
hicle (lanes A, C, E, and G) or 500 rig/ml hGH 
(lanes B, D, F, and H-M) for 5 min. Solubilized 
proteins were immunoprecipitated using aGH 
(1:4000; lanes A, 8, E, F, I, J, L, and M), aGHR- 
Cl (-0.1 &ml; lanes C, D, G, and H), or 
aJAK2 (1:lOoO; lane K). The precipitated pro- 
teins were subjected to Western blotting using 
GH: - + - + - + - + + +-r ++ aJAK2 (lanes A-D), aPY-4GlO (lanes E-H, J, 
1st IP: aGH aGHR aGH aGHR aGH aGH oJAK2 aGH and K) or aGHR-Cl (-0.1 ug/ml; lane I). For 
2nd IP: - - - - - - _ aJAK2 
the samples for lanes L and M, the precipitate 
Blot: aJAK2 aPY aGHR aPY aPY aJAK2 
was washed and boiled in buffer containing 
SDS, P-mercaptoethanol. and DlT, as de- 
scribed in Experimental Procedures. Samples 
were diluted 19fold with lysis buffer, immunoprecipitated with aJAW (l:lOOO), and Western blotted using ePY4GtO (lane L) or aJAK2 (lane u). 
LaneS A-H are from one experiment, lane I from a second, lanes J and K from a third, and lanes L and M from a foufth. The migrations of JAW 
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Figure 4. JAK2 Is Associated with GHR and Is Phosphorylated In Vitro 
CH04 cells were incubated at 25OC in the absence (lanes A, C, and 
E) or presence (lanes 8, D, and F) of 30 nglml hGH for 60 min. Cellular 
proteins were s&bilked, immunoprecipitated using aGH, and incu- 
bated with [T-=P]ATP. Immune complexes and associated proteins 
were treated with SDS, 5-mercaptoethanol, and DTT. The dissociated 
proteins were diluted. Samples were then removed for analysis by 
SDS-PAGE (150 ~1; lanes A and B) or reimmunoprecipitated (550 pl) 
with aJAK2 (lanes C and D) or aGHR (aGHBP-poly; lanes E and F) 
as described in Experimental Procedures. 32P-labeled proteins were 
resolved by SDS-PAGE and visualized by autoradiography. The mo- 
lecular weight (x IO-3 of protein standards and the migration of ppl30 

















. ..g :, p  : 
.‘. : ! 
-  &Qr :a: .;. 
lx.4~ -  * Gt+ -  + 
lane I). The finding that tyrosyl residues are phosphory- 
lated in the diffuse 120 kd protein present in aGHR immu- 
noprecipitates only when the cells have been incubated 
with GH (Figure 3, lanes G and H) offers evidence that 
tyrosyl phosphorylation of GHR, like tyrosyl phosphoryla- 
tion of JAK2, is GH dependent. Additional evidence that 
both JAK2 and GHR are tyrosyl phosphorylated in re- 
sponse to GH is provided by the finding that in a 
transfected Chinese hamster ovary cell line (CH04) that 
expresses a smaller (84 kd) GHR (Emtner et al., 1990; 
Wang et al., 1993), tyrosyl phosphorylation of a 130 kd 
protein in aGH, aGHR, and aJAK2 immunoprecipitates 
and a diffusely migrating 84 kd protein in aGH and aGHR 
immunoprecipitates is GH dependent (data not shown). 
Stimulation by GH of JAK2 Kinase Activity 
Previous studies have established that when aGH precipi- 
tates are prepared from GH-treated CH04 cells, the addi- 
tion of ATP results in the tyrosyl phosphorylation of both 
a 130 kd and a 84 kd protein (Wang et al., 1993). To deter- 
mine whether the 130 kd and 84 kd proteins phosphory- 
lated in this in vitro kinase assay are JAK2 and GHR, re- 
spectively, GH-GHR complexes and associated proteins 
were precipitated from GH-treated CH04 cells using aGH, 
incubated with [Y-~P]ATP, dissociated by boiling in buffer 
containing SDS, 8-mercaptoethanol, and dithiothreitol 
(Dll), and reprecipitated using either aJAK2 or aGHR. 
The ability of aJAK2 to precipitate a 130 kd 32P-labeled 
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Figure 5. Purified JAKP Possesses Tyrosine Kinase Activity 
(A) 3T3-F442A cells were incubated at 25% in the absence (lanes A 
and C) or presence (lanes B and D) of 30 nglml hGH for 1 hr. Solubilized 
proteins were immunoprecipitated using aJAK2 (lanes A and B) or 
sequentially immunoprecipitated using first aPY and then aJAK2 
(lanes C and D) and incubated with [y-“P]ATP as described in Experi- 
mental Procedures. The molecular weight (x lOma) of protein stan- 
dards and migration of pp130 are indicated. 
(B) pp130 was excised from the gel visualized in lane B of (A) and 
subjected to limited acid hydrolysis at 109% for 1.25 hr. Following 
partial purification on Dowex-50, fractions containing O-phosphoser- 
ine and 0-phosphothreonine (lane A) or 0-phosphotyrosine (lane B) 
were resolved by thin layer electrophoresis (pH 3.5) as previously de- 
scribed (Carte&u et al., 1969; Stred et al., 1990; Wang et al., 1992). 
The migrations of 0-phosphoserine (P-Ser), 0-phosphothreonine 
(P-Thr), and 0-phosphotyrosine (P-Tyr) standards are indicated by the 
dashed circles. 
protein appropriate for JAK2 (Figure 4, lane D), as well as 
the ability of aGHR to precipitate an 84 kd 32P-labeled 
protein appropriate for GHR (Figure 4, lane F), indicates 
that both JAK2 and GHR incorporate 32P in the in vitro 
kinase assay. 
To verify that JAK2 functions as a GH-dependent tyro- 
sine kinase, JAK2 was purified from GH-treated and con- 
trol 3T3-F442A cells either by direct immunoprecipitation 
withaJAK2(Figure5A,lanesAandB)or, topermit ahigher 
degree of purificatioo, by sequential immunoprecipitation 
using aPY followed by aJAK2 (Figure 5A, lanes C and D). 
When the aJAK2 immune complexes were incubated with 
[?I-“P]ATP, %P-labeled proteins migrating with a M, 
(130,000) appropriate for JAKP were detected only when 
the cells had been incubated with GH (Figure 5A, lanes 
B and D), indicating an exquisite sensitivity of JAKP to 
activation by GH. To verify that JAK2 incorporates phos- 
phate into tyrosyl residues, phosphoamino acid analysis 
was performed on the =P-labeled 130 kd protein isolated 
from GH-treated 3T3-F442A cells (Figure 5A, lane B). “P 
was incorporated almost exclusively into tyrosyl residues 
(Figure 5B), consistent with JAK2 being a GH-sensitive 
tyrosine kinase. However, the incorporation of a small 
amount of =P (under 1%) into threonine residues in the 
aJAK2 immunoprecipitate leaves open the possibility that 
JAK2 is a mixed function threonine/serine/tyrosine kinase. 
JAK2 Is a GHR-Associated Tyrosine Kinase 
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Discussion 
identification of JAK2 As a Signaling Molecule 
for GHR 
The identification of JAK2 as a GH-dependent, GHR- 
associated tyrosine kinase has important implications for 
signal transduction by both GHR and JAKP. With regard 
to GHR, JAK2 is identified as a signaling molecule that 
interacts with GHR and is activated in response to GH 
binding. its sensitivity to GH and rapid onset following GH 
addition make tyrosyi phosphoryiation of JAKP among the 
most sensitive and rapid responses known for GH, raising 
the possibility that activation of JAK2 is the initiating step 
for GH signal transduction. Tyrosine kinases have been 
shown to elicit responses similar to those attributable to 
GH, including metabolic responses (e.g., insulin receptor) 
and differentiation (e.g., nerve growth factor receptor) (re- 
viewed by Davidson, 1987; isaksson et al., 1987; Levi- 
Montaicini, 1987; Kaplan et al., 1991). Therefore, it seems 
likely that JAK2 plays a vital role in eliciting at least some 
of the known responses to GH. Consistent with this, no 
biological functions, other than binding of GH, have been 
reported for GHR expressed in ceils that have low levels 
of GHR-associated tyrosine kinase activity (e.g., COS-7 
and mouse L ceils; Leung et al., 1987; Wang et al., 1992, 
and unpublished data). in contrast, a variety of biological 
functions (e.g., insulin synthesis in RINSAH ceils and pro- 
tein synthesis, microtubule-associated protein kinase ac- 
tivity, c-fosgene expression, and lipid synthesis in Chinese 
hamster ovary cells) can be activated by GH binding when 
the cloned liver GHR is expressed in ceils that have rea- 
sonably high levels of GHR-associated kinase activity (Bii- 
lestrup et al., 1990; Emtner et al., 1990; Moller et al., 1992; 
Wang et al., 1992; Moller, 1992; Wang et al., submitted). 
Furthermore, in 3T3-F442A ceils, multiple proteins exhibit 
GH-dependent increases in tyrosyl phosphoryiation. Con- 
sistent with activation of JAK2 being required for these 
phosphoryiations, tyrosyi phosphoryiation of JAK2/pp121 
is simultaneous with or precedes tyrosyl phosphorylation 
of ail the proteins exhibiting GH-dependent tyrosyl phos- 
phoryiation, at ail GH concentrations tested (this work and 
Campbell et al., 1993). 
Presumably, JAK2 serves as a signaling molecule for 
GHR by phosphoryiating other proteins. Thus far, only two 
proteins have been identified as likefy substrates of JAK2: 
JAK2 itself and GHR. Studies using truncated GHR indi- 
cate that in the cytopiasmic domain of the GHR, at least 
1 of the 4 tyrosyl residues most proximal to the membrane 
is phosphorylated in response to GH (Wang et al., submit- 
ted). Studies are underway to identify which of the 4 tyro- 
sines are phosphoryiated by JAK2, as well as to identify 
tyrosines in the C-terminal portion of GHR that might also 
be phosphorylated. it is important to determine the identity 
and number of tyrosines phosphorylated in JAK2 and 
GHR, because these sites are likely to be binding sites 
for SHPcontaining proteins (e.g., phospholipase C-y, ~85 
phosphatidyiinositoi3 kinase, and GTPase-activating pro- 
tein; Koch et al., 1991) in intracellular signaling pathways. 
Signaling pathways involving SH2-containing proteins 
that bind to phosphorylated JAK2 would be expected to 
be shared by ail iigands that activate JAKP, whereas SH2- 
containing proteins that bind to phosphotylated tyrosyl res- 
idues in GHR could provide specificity to a signaling mech- 
anism that utilizes a kinase (i.e., JAK2) with the apparent 
capacity to service more than one receptor (see below). 
JAK2 has also been shown to be activated following the 
binding of EPO to its receptor(Witthuhn et al., 1993). Other 
data indicate that IL-3, GM-CSF, G-CSF, IFN--r, and pro- 
lactin also activate JAK2 (Siivennoinen et al., 1993; 
Witthuhn et al., 1993; 0. S. et al., unpublished data; 
G. S. C. et al., unpublished data). Thus, it appears that 
JAKP serves as a kinase for multiple members of the cy- 
tokinelhematopoietin receptor family. Since each ligand 
elicits a separate constellation of responses, kinase acti- 
vation alone cannot account for specificity. As mentioned 
above, a set of responses dependent upon phosphoryla- 
tion of the receptor could provide this specificity. Addition- 
ally, specificity could be obtained by interaction between 
multiple signaling pathways or by the expression of only 
one receptor type in a particular ceil type. This latter mech- 
anism is suggested by the ability of GH, G-CSF, and EPO 
to stimulate proliferation of iL+dependent ceils trans- 
fected with the cDNA for the appropriate receptor (Fuku- 
naga et al., 1991; Ishizaka-lkeda et al., 1993; Yoshimura 
et al., 1990). 
The commonality of JAK2 activation suggests that there 
will be shared pathways activated by the ligands that bind 
JAKP-coupled receptors. Of particular interest for gaining 
insight into regulation of gene transcription by GH is a 
pathway initiated by IFN-y. In response to IFN?, the 91 
kd protein of the ISGF3 (IFN-stimulated gene factor 3) 
complex undergoes tyrosyi phosphorylation and then 
transiocates to the nucleus, where it binds to DNA at the 
y-activated site (Shuai et al., 1992). Identification of the 
90 kd protein phosphoryiated in response toGH (Campbell 
et al., 1993) as the 91 kd protein of the ISGF-3 complex 
or a family member would implicate one pathway by which 
GH might elicit some of its effects on gene transcription. 
Activation of JAK2 by GH 
The exact mechanism by which GH activates JAK2 is not 
yet known. Earlier studies using an exogenous substrate 
(poiy Giu, Tyr) established that more tyrosine kinase activ- 
ity is present in a complex with GHR when GHR is pre- 
pared from GH-treated cells than from control ceils (Stred 
et al., 1992). The present study suggests that this GH- 
induced increase in kinase activity results from both an 
increase in affinity of GHR for JAK2 and an increase in 
JAKP activity. JAK2 appears to bind directly to GHR, since 
only two proteins, migrating with sizes appropriate for 
JAK2 and GHR, arevisualized when highly purified kinase- 
active GH-GHR complexes are isolated from GH-treated 
35S-iabeled 3T3-F442A fibroblasts by sequential immuno- 
precipitation using aPY and then either aGHR or aGH 
(Stred et al., 1992). The mechanism by which GH pro- 
motes association of JAK2 with GHR and JAK2 activation 
is likely to require dimerization of GHR, since GH-induced 
tyrosyl phosphorylation of cellular proteins appears to re- 
quire dimerization of GHR (Silvaet al., 1993). An important 
role for receptor dimerization in signaling via JAK2 is fur- 
ther suggested by work relating JAK2 activation to EPO 
receptor dimerization discussed by Witthuhn et al. (1993). 
On the basis of these findings, we hypothesize that the 
binding of GH by GHR results in the formation of a ligand- 
bound GHR dimer capable of binding JAKP. Recruitment 
of JAKP leads to the formation of a GH-GHRJAK2 com- 
plex, stimulation of JAK2 tyrosine kinase activity, and ty- 
rosy1 phosphorylation of JAKP, GHR, and presumably 
other proteins. Whether activated JAK2 is present only in 
a complex with GHR or can dissociate from GHR and 
phosphorylate proteins that are physically distant from 
GHR is currently being investigated. Also under investiga- 
tion is the possibility that GHR can form complexes with 
kinases other than, or in addition to, JAK2. Obvious candi- 
date kinases include other members of the JAK family. In 
3T3-F442A and IM-9 cells, respectively, JAKl and Tyk2 
do not appear to associate with GHR to the same extent 
as JAK2. However, they or other as yet unidentified JAK 
kinases may do so in other cell types or under different 
physiological conditions. 
It will be intriguing to determine whether the interactions 
between JAK2 and the receptors for 11-3, EPO, GM-CSF, 
G-CSF, prolactin, and IFN-y, like the interaction between 
JAK2 and GHR, is ligand dependent. In the accompanying 
paper (Witthuhn et al., 1993) JAK2 from either EPO- 
stimulated or unstimulated cells is reported to bind to a 
fusion protein composed of glutathione S-transferase and 
the cytoplasmic domain of the EPO receptor. This sug- 
gests that JAK2 may be constitutively associated with 
some of the receptors capable of activating JAK2. 
cedars. The findina that GHR shares an imoortant and 
In summary, the experiments presented in the present 
paper, in combination with the similar findings for the EPO 
receptor presented in the accompanying paper and other 
work with the receptors for IL-3, GM-CSF, G-CSF, prolac- 
tin, and IFNr (Silvennoinen et al., 1993; Witthuhn et al., 
1993; 0. S. et al., unpublished data: G. S. C. et al.. unoub- 
lished data), suggest that the activation of JAK2 kinase 
activity by GH and EPO by a mechanism involving a JAK2- 
receptor complex may be a prototype for signaling by 
many members of the cytokinelhematopoietin family re- 
Experimental Procedures 
Materials 
Stocks of 3T3-F442A and CH04 cells were kind gifts of H. Green 
(Harvard University, Cambridge, MA)andG. Norstedt (Karolinska Insti- 
tute, Novum, Sweden), respectively. Recombinant human GH (hGH) 
was provided by Eli Lilly. Platelet-derived growth factor (recombinant 
human BB) and recombinant epidermal growth factor came from Col- 
laborative Research. Recombinant insulin-like growth factor 1 was a 
giff of Kabi/Pharmacia. Triton X-100 (Surfact-Amps X-100) came from 
Pierce Chemical Company, aprotinin and leupeptin from Boehringer 
Mannheim, recombinant protein A-agarose from Repligen, [T-yP]ATP 
(8000 Cilmmol) from New England Nuclear Corporation, and the en- 
Antlbodles 
aGH (NIDDK-anti-hGH-IC3, lot Cl 1981) came from the National Insti- 
tute of Diabetes and Digestive and Kidney Diseases/National Hormone 
and Pituitary Program, University of Maryland School of Medicine (Bal- 
timore). aPY-Shafer was a gift of Dr. J. A. Shafer (Merck, Sharp, and 
Dohme Research Laboratory, West Point, PA: Pang et al., 1985) and 
aPY-4GlO was purchased from UBI. aJAK2 was prepared in rabbits 
against a synthetic peptide corresponding to the hinge region between 
domains 1 and 2 of murine JAK2 (amino acids 758-778; Silvennoinen 
et al., 1993). cJAK1 was prepared against a synthetic peptide to a 
corresponding region in murine JAKI (amino acids 788-804; Silven- 
noinen et al., 1993). One aGHR (aGHR-Cl) was prepared in rabbits 
against a fusion protein composed of glutathione S-transferase fused 
to the cytoplasmic domain of the cloned mouse liver GHR and affinity 
purified using immobilized GHR cytoplasmic domain (L. S. A. et al., 
unpublished data). A second aGHR (aGHBP-poly), kindly provided 
by Dr. W. R. Baumbach (American Cyanamid, Princeton, NJ), was 
produced in rabbits using recombinant rat GH-binding protein pro- 
duced in Escherichia coli (Sadeghi et al., 1990). aTyk2 was a gift of 
Dr. J. J. Krolewski (Columbia University, New York). aGLUT- was 
prepared in rabbits using band 4.5 purified from human erythrocytes. 
It recognizes both human and rodent GLUT-l (Tai et al., 1990). 
lmmunopreclpltation and Western Blotting 
Cells were grown to confluence and deprived of serum overnight as 
iO% SDS, 10% 8-mercaptoethanol,.40% glycerol). Unfractionated 
described previously (Wang et al., 1993). Cells were incubated for the 
indicated times with hormone or growth factor as indicated at 37OC 
in 95% air, 5% CO,, rinsed with three changes of ice-cold 10 mM 
sodium phosphate(pH 7.4) 137 mM NaCI, 1 mM Na,VO,, and scraped 
in lysis buffer (50 mM Tris [pH 7.5],0.1% Triton X-100, 137 mM NaCI, 
2 mM EGTA, 1 mM Na,VO,, 1 mM phenylmethylsulfonyl fluoride, 10 
uglml aprotinin, and 10 pg/ml leupeptin) on ice. Cell lysates were 
centrifuged at 12,000 x g for 10 min, and the resulting supernatants 
were incubated on ice for 90 min with the indicated antibodv. Immune 
complexes were collected on protein A-agarose during a 30-80 min 
incubation at 8“C, washed three times with wash buffer (50 mM Tris 
[pH 7.51, 0.1% Triton X-100, 137 mM NaCI, 2 mM EGTA) and boiled 
for 5 min in a mixture (80~20) of lysis buffer and SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) sample buffer (250 mM Tris [pH 8.81, 
early signaling molecule with other members of the cyto- 
kinelhematopoietin receptor family suggests that GH, 
IL-3, EPO, prolactin, GM-CSF, G-CSF and IFN--r are likely 
to share some signaling pathways. However, specificity 
could still be achieved, since phosphorylation of each re- 
ceptor offers signaling capabilities unique to each ligand. 
The variable expression of individual receptors, the poten- 
tial presence of only a subset of all possible signaling path- 
ways in different.cell types, and regulation of the signaling 
molecules in these pathways by other stimuli permits an 
additional level of specificity. This finding is likely to lead 
to the identification of new actions for GH as well as for 
lysates were brought to the same final concentrations of Tris, SDS, 
f&mercaptoethanol, and glycerol and boiled for 5 min. The immunopre- 
cipitates and lysates were subjected to SDS-PAGE followed by West- 
ern blot analvsis with the indicated antibodv f1:5000 dilution unless , . 
noted otherwise) using the enhanced chemiluminescence detection 
system (Campbell et al., 1993). In some experiments, the proteins 
were dissociated from the immune complexes and then reimmunopre- 
cipitated before analysis by Western blot. 
Dissociation and Relmmunopreclpltatlon of 
Immune Complexes 
The immune complexes from the initial immunoprecipitation were 
washed once with 50 mM Tris, 137 mM NaCl (pH 7.5) brought to a 
final concentration of 0.75% SDS, 2% 8-mercaptoethanol, 100 mM 
DTT, 100 t&g/ml aprotinin, and 100 vglml leupeptin by addition of an 
these other cytokines. equal volume of a2 x concentrated stock, and then boiled for 5 min. 
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The eluted proteins were diluted IO-fold with lysis buffer. A portion was 
removed, mixed (80:20) with SDS-PAGE sample buffer, and boiled for 
5 min. The remaining sample was incubated with the second antiserum 
on ice for 60-90 min and with protein A-agarose at 8OC for 1 hr. The 
immune complexes were washed three times with lysis buffer and 
boiled for 5 min in a mixture (80:20) of wash buffer and SDS-PAGE 
sample buffer. 
Immunoprecipitatlon for Klnase Assays 
Serum-deprived cells were incubated at 25“C in the absence or pres- 
ence of 30 rig/ml hGH for 60 min. The relatively long incubation period, 
low GH concentration, and low temperature were used to maximize 
the in vitro incorporation of 32P into pp130 and GHR during the kinase 
assay. Cells were washed with phosphate-buffered saline, solubilized 
in 25 mM HEPES. 2 mM NaVO,, 0.1% Triton X-100, 0.5 mM DTT, 1 
mM phenylmethylsulfonyl fluoride, 10 pglml aprotinin, 10 pg/ml leu- 
peptin (pH 7.4) (HVT), and centrifuged at 200,000 x g for 1 hr at 4OC. 
Soluble proteins were incubated on ice for 1 hr with either aGH 
(l:iO,OOO dilution), uPY-Shafer (15 ng per plate of cells), or aJAK2 
(1:1,500 dilution) (Carte&u et al., 1989). Protein A-agarose was 
added for an additional 1 hr at 8OC. Immune complexes were washed 
three times with 50 mM HEPES, 150 mM NaCI, 0.1% Triton X-l 00, 
0.5 mM DTT (pH 7.6) (NHT) and then once with 50 mM HEPES, 100 
mM NaCI, 6.25 mM MnC12, 0.1% Triton X-100, 0.5 mM DTT (pH 7.6) 
(HNMT). 
Sequential lmmunoprecipitatlon with aPY and aJAK2 
Proteins immobilized on aPY-protein A-agarose complexes were 
transferred to a small plastic column and equilibrated for 5 min with 
10 mM p-nitrophenyl phosphate, 20 nglml aprotinin, 20 rig/ml leupeptin 
in HNMT (eluting buffer). Phosphoproteins were then eluted with 180 
ul of eluting buffer. aJAK2 (1:200 dilution) was added, and the mixture 
was incubated on ice for 1 hr. Protein A-agarose and 0.7 ml of HNMT 
containing 20 @ml aprotinin, 20 pg./ml leupeptin (phosphorylation 
buffer) was added, and incubation continued at 8OC for 1 hr. Immune 
complexes were washed three times with NHT and once with phos- 
phorylation buffer. 
In Vitro Kinase Assay and Phosphoamino Acid Analysis 
Proteins immobilized on aJAK2 or aGH were mixed with 95 ul of phos- 
phorylation buffer. [y-=PjATPwas then added to yield a final concentra- 
tion of 10 PM ATP and 5 mM MnCI,. After 10 min at 30°C, the reaction 
was stopped with the addition of 10 mM EDTA in NHT. The immune 
complexes were washed three times with NHT and once with phos- 
phorylation buffer. 32P-labeled proteins were either subjected to a sec- 
ond immunoprecipitation or boiled for 5 min in SDS-PAGE sample 
buffer, resolved by SDS-PAGE, and visualized by autoradiography. 
The phosphoamino acid content of phosphorylated proteins was deter- 
mined by limited acid hydrolysis using a modification of the procedure 
of Hunter and Sefton (1980) as described previously (Carter-Su et al., 
1989; Stred et al., 1990; Wang et al., 1992). 
SDS-PAGE and Densitometry 
Proteins were separated by SDS-PAGE on 3%-10% gradient gels 
(30:0.05 acrylamide:bisacrylamide) as described previously (Carter- 
Su et al., 1989). Densitometry was performed using a Bio-Med Instru- 
ments laser scanning densitometer attached to an Apple IIE computer 
(BioMed Instruments Videophoresis II data analysis computer program), 
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